MLN3126 Single Rising Dose Study

NCT02447458 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Stopped Site non-compliance to GCP (No safety concerns. See detailed description)

Conditions

Healthy Volunteers

Interventions

DRUG: MLN3126
DRUG: MLN3126 Placebo

Sponsor

Takeda